|
Index of reports
> Cases with Graft Versus Host Disease (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vivaglobin (Immune Globulin Subcutaneous Human) where reactions include graft versus host disease. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Vivaglobin side effects in 51 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-27
Patient: 51 year old male
Reactions: Polydipsia, Incorrect Route of Drug Administration, Graft Versus Host Disease, Cytomegalovirus Test Positive, Diabetes Mellitus, Polyuria, Off Label Use, Bone Marrow Disorder, Haemoglobin Decreased, Thrombocytopenia, Leukopenia, White Blood Cell Count Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vivaglobin
Dosage: 6.4 g 1x/week, 160mg/ml every 7 days intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-10-25
Noxafil
Start date: 2011-07-15
End date: 2011-09-26
ACT HIB (Haemophilus B Conjugate Vaccine)
Indication: Immunisation
Start date: 2011-09-26
End date: 2011-09-26
ACT HIB (Haemophilus B Conjugate Vaccine)
Indication: Immunisation
Start date: 2011-11-08
End date: 2011-11-08
Other drugs received by patient: Foscavir; Prednisone TAB; Ganciclovir
Possible Vivaglobin side effects in 51 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-05
Patient: 51 year old male
Reactions: Incorrect Route of Drug Administration, White Blood Cell Count Decreased, Polydipsia, Graft Versus Host Disease, Cytomegalovirus Test Positive, Polyuria, Haemoglobin Decreased, Bone Marrow Disorder, Off Label Use, Thrombocytopenia, White Blood Cell Count Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vivaglobin
Other drugs received by patient: Ganciclovir; Voriconazole; Prednisone TAB; ACT HIB (Haemophilus B Conjugate Vaccine)
|
